Drug intelligence / Profile preview

ibuprofen + chlorphenamine maleate

Development stage
Unknown
Lead developer
HALEON
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + chlorphenamine maleate is a fixed-dose combination small-molecule drug used for the symptomatic relief of the common cold, influenza, and upper respiratory tract infections. It combines ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) that reversibly inhibits cyclooxygenase enzymes (COX-1 and COX-2) to reduce pain, fever, and inflammation, with chlorphenamine maleate (chlorpheniramine maleate), a first-generation H1 histamine receptor antagonist that relieves symptoms such as runny nose, sneezing, and watery eyes. This combination is marketed under brand names such as Niofen Cold HBP and has been utilized as an active control in clinical trials evaluating natural plant extracts for the common cold.

Brand names
Niofen Cold HBP
Other names
ibuprofen + chlorpheniramine maleateibuprofen and chlorpheniramine maleateibuprofen and chlorphenamine maleate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on ibuprofen + chlorphenamine maleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + chlorphenamine maleate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call